Journal
PATHOLOGY & ONCOLOGY RESEARCH
Volume 26, Issue 2, Pages 813-819Publisher
FRONTIERS MEDIA SA
DOI: 10.1007/s12253-019-00617-0
Keywords
Syndecan-1; Liver; Cirrhosis; Metastasis; Hepatocellular carcinoma
Ask authors/readers for more resources
Liver diseases such as liver cirrhosis, primary and metastatic liver cancers are still a major medical challenge. Syndecan-1 is one of the most important proteoglycans in the liver. Syndecan-1 is normally expressed on the surfaces of hepatocytes and cholangiocytes. Due to liver diseases the amount of syndecan-1 increases in the liver. Despite the emerging data of the biological function of syndecan-1, the clinical usefulness of this proteoglycan is still unknown. In our study we correlated syndecan-1 expression to clinico-pathological data. We found that syndecan-1 proved to be a good marker for hepatitis C virus based hepatocellular carcinoma and increased with liver dysfunction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available